Clarivate
SEPTEMBER 18, 2023
As a pioneer in automated indexing and retrieval of information since 1955, Eugene Garfield (1925-2017) developed citation databases for science that changed how researchers search and assess the scholarly literature.
Clarivate
APRIL 21, 2022
As can be seen from Figure 1, between 2017-2021, Ukraine’s research output focused on macro topics such as physics (19%), clinical and life sciences (16%), chemistry (16%), social sciences (12%), engineering and material sciences (10%), and electrical engineering (10%) with a total of 52,618 papers published. Source: InCites.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
World of DTC Marketing
DECEMBER 2, 2021
The FDA wrote, “the researchers concluded that drug companies who create drug advertisements, as well as regulators who are responsible for reviewing promotional material, should pay special attention to ensuring that images accurately reflect drug efficacy.” ” Uh…no.
Pharmaceutical Technology
JANUARY 23, 2023
The few approvals within paediatrics can be seen to be contributing to the numerous challenges associated with these studies; the smaller patient population, in addition to special measures required to ensure the ethics and safety of these trials, which all leads to trial delays, extended studies, and higher costs.
pharmaphorum
JANUARY 5, 2023
In 2017, reSET became the first FDA-approved DTx with both a safety and efficacy label, after the US regulator licensed it for substance use disorders involving alcohol, cocaine, marijuana, and stimulants. The extended agreement comes shortly after Pear reported a 24% quarter-over-quarter increase in revenues to $4.1
LEVO Health
JANUARY 18, 2023
According to the Accenture report, 30% of people selected a new provider in 2021 (up from 26% in 2017), and 25% of those individuals switched providers because they were unhappy (up 18% from 2017). Patients are Holding Providers Accountable.
pharmaphorum
JULY 4, 2022
At Teva , he replaces Hafrun Fridriksdottir, a 25-year Teva veteran who was named R&D chief almost immediately after Kare Schultz took over the reins of Teva in 2017 with the task of turning around the fortunes of the ailing generics giant. He will be based out of Teva’s US headquarters in Parsippany, New Jersey.
Expert insights. Personalized for you.
119 
Let's personalize your content